Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03205176 |
Title | Phase I Study of AZD5153 in Patients With Relapsed or Refractory Solid Tumors and Lymphomas |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | AstraZeneca |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | CAN |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Research Site | Sarasota | Florida | 34232 | United States | Details | |
Research Site | Oklahoma City | Oklahoma | 73104 | United States | Details | |
Research Site | Nashville | Tennessee | 37203 | United States | Details | |
Research Site | Toronto | CA | M5G 2M9 | Canada | Details |